Alto Neuroscience, Inc.

Historical 13F Holders

Symbol
ANRO
CUSIP
02157Q109
All holders as of
Q3 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 02157Q109 since 12/18/2024, largest first.

Filer % of Class Filed
Perceptive Advisors LLC 13G/A
10.0% 8/14/2026
Event 6/30/2026
Commodore Capital LP 13G/A
9.9% 5/15/2026
Event 3/31/2026
Sirenia Capital Management LP 13G/A
6.2% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G 6.0% 7/27/2026
Event 6/30/2026
EcoR1 Capital, LLC 13G
5.8% 7/20/2026
Event 7/13/2026
Vanguard Capital Management LLC 13G 5.0% 10/30/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Armistice Capital, LLC 13G/A
4.9% 2/18/2026
Event 12/31/2025
FMR LLC 13G/A
4.7% 2/12/2025
Event 12/31/2024
Point72 Asset Management, L.P. 13G/A
3.7% 5/15/2026
Event 3/31/2026
K2 HealthVentures Equity Trust LLC 13G/A
2.4% 2/17/2026
Event 12/31/2025
Vestal Point Capital, LP 13G/A
2.2% 8/14/2026
Event 6/30/2026
RA Capital Management, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 134 38.9 M $992M
2026 Q2 116 29.5 M $778M
2026 Q1 111 26.8 M $602M
2025 Q4 97 24.5 M $436M
2025 Q3 77 16.8 M $67.4M
2025 Q2 82 17.3 M $38.1M
2025 Q1 84 20.8 M $45.0M
2024 Q4 78 22.5 M $95.3M
2024 Q3 84 22.9 M $265M
2024 Q2 59 18.6 M $199M
2024 Q1 54 16.0 M $246M